Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
6.15
+0.23 (3.89%)
At close: Jun 17, 2026, 4:00 PM EDT
6.27
+0.12 (1.95%)
After-hours: Jun 17, 2026, 5:41 PM EDT
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $334.68 million as of June 17, 2026. Its market cap has decreased by -42.61% in one year.
Market Cap
334.68M
Enterprise Value
41.22M
1-Year Change
-42.61%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has decreased from $393.35M to $334.68M, a decrease of -14.91%. That is a compound annual growth rate of -9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 334.68M | -77.19% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 357.70M |
| Vanda Pharmaceuticals | 355.40M |
| Greenwich LifeSciences | 355.21M |
| Enanta Pharmaceuticals | 347.49M |
| Opus Genetics | 336.16M |
| OmniAb | 334.16M |
| Silence Therapeutics | 323.79M |
| Lyell Immunopharma | 322.83M |